117 related articles for article (PubMed ID: 29663037)
1. Polyfunctionality of CD4
Doescher J; Jeske S; Weissinger SE; Brunner C; Laban S; Bölke E; Hoffmann TK; Whiteside TL; Schuler PJ
Strahlenther Onkol; 2018 May; 194(5):392-402. PubMed ID: 29663037
[TBL] [Abstract][Full Text] [Related]
2. [Long-term changes in peripheral blood leukocyte and lymphocyte populations in ENT-carcinoma patients. A flow cytometric study in 346 ENT-carcinoma patients and 31 healthy controls].
Ostwald J; Dommerich S; Schulz U; Kramp B
HNO; 2004 Aug; 52(8):685-92. PubMed ID: 15257393
[TBL] [Abstract][Full Text] [Related]
3. Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.
Schuler PJ; Harasymczuk M; Schilling B; Saze Z; Strauss L; Lang S; Johnson JT; Whiteside TL
Clin Cancer Res; 2013 Dec; 19(23):6585-96. PubMed ID: 24097865
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M
Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
6. Mononuclear phagocytes in head and neck squamous cell carcinoma.
Kross KW; Heimdal JH; Aarstad HJ
Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):335-44. PubMed ID: 19967383
[TBL] [Abstract][Full Text] [Related]
7. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
8. A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN).
Grover S; Mitra N; Wan F; Lukens JN; Sharma S; Bauman J; Masroor F; Cohen RB; Desai A; Algazy K; Alonso-Basanta M; Ahn P; Kevin Teo BK; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Am J Clin Oncol; 2016 Oct; 39(5):522-7. PubMed ID: 27441910
[TBL] [Abstract][Full Text] [Related]
9. Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer.
Theodoraki MN; Lorenz K; Lotfi R; Fürst D; Tsamadou C; Jaekle S; Mytilineos J; Brunner C; Theodorakis J; Hoffmann TK; Laban S; Schuler PJ
Photodiagnosis Photodyn Ther; 2017 Sep; 19():194-201. PubMed ID: 28578124
[TBL] [Abstract][Full Text] [Related]
10. [T-cells activated with a trifunctional bi-specific antibody in head and neck cancer].
Gronau S; Schmitt M; Reinhardt P; Wiesneth M; Riechelmann H
Laryngorhinootologie; 2005 Nov; 84(11):822-8. PubMed ID: 16358189
[TBL] [Abstract][Full Text] [Related]
11. Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma.
Krupar R; Hautmann MG; Pathak RR; Varier I; McLaren C; Gaag D; Hellerbrand C; Evert M; Laban S; Idel C; Sandulache V; Perner S; Bosserhoff AK; Sikora AG
Am J Pathol; 2018 Jan; 188(1):72-83. PubMed ID: 29107073
[TBL] [Abstract][Full Text] [Related]
12. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
13. [Immunosuppression caused by head and neck surgery].
Heimlich F; Dietz A; Daniel V; Maier H
HNO; 1999 Oct; 47(10):885-92. PubMed ID: 10550372
[TBL] [Abstract][Full Text] [Related]
14. Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression.
Dong J; Cheng L; Zhao M; Pan X; Feng Z; Wang D
Tumour Biol; 2017 May; 39(5):1010428317701651. PubMed ID: 28466780
[TBL] [Abstract][Full Text] [Related]
15. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
[TBL] [Abstract][Full Text] [Related]
16. T cell abundance in blood predicts acute organ toxicity in chemoradiotherapy for head and neck cancer.
Beschel LM; Leu M; Reichardt SD; Rave-Fränk M; Schirmer MA; Stadelmann C; Canis M; Wolff HA; Reichardt HM
Oncotarget; 2016 Oct; 7(40):65902-65915. PubMed ID: 27589568
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
18. BCG immune activation reduces growth and angiogenesis in an in vitro model of head and neck squamous cell carcinoma.
Sánchez-Rodríguez C; Cruces KP; Riestra Ayora J; Martín-Sanz E; Sanz-Fernández R
Vaccine; 2017 Nov; 35(47):6395-6403. PubMed ID: 29029943
[TBL] [Abstract][Full Text] [Related]
19. Molecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC).
Azoury SC; Gilmore RC; Shukla V
Discov Med; 2016 Jun; 21(118):507-16. PubMed ID: 27448787
[TBL] [Abstract][Full Text] [Related]
20. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
Okada K; Yasumura S; Muller-Fleckenstein I; Fleckenstein B; Talib S; Koldovsky U; Whiteside TL
Cell Immunol; 1997 Apr; 177(1):35-48. PubMed ID: 9140094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
